nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Clinical Use of Recombinant FVIIa (rFVIIa)
|
Hedner, Ulla |
|
1998 |
19 |
2 |
p. 163-176 14 p. |
artikel |
2 |
Computer Assisted Prospective Review of Blood Product Utilization: A Large Hospital Experience
|
Silva, Victor A |
|
1998 |
19 |
2 |
p. 121-127 7 p. |
artikel |
3 |
Editorial
|
|
|
1998 |
19 |
2 |
p. 137-138 2 p. |
artikel |
4 |
Editorial
|
|
|
1998 |
19 |
2 |
p. 109- 1 p. |
artikel |
5 |
International Forum Consensus Conference on Platelet Transfusion. Final Statement
|
Contreras, Marcela |
|
1998 |
19 |
2 |
p. 111-114 4 p. |
artikel |
6 |
International Forum Hepatitis C Virus RNA Testing by Nested PCR in Blood Preparations in Yugoslavia
|
Alavantic, Dragan |
|
1998 |
19 |
2 |
p. 115-117 3 p. |
artikel |
7 |
Mammalian Recombinant Coagulation Proteins: Structure and Function
|
White, II, Gilbert C |
|
1998 |
19 |
2 |
p. 177-189 13 p. |
artikel |
8 |
Patent report
|
|
|
1998 |
19 |
2 |
p. I-VII nvt p. |
artikel |
9 |
Plasmapheresis in Myasthenia Gravis. 1 1 This paper has been presented at a symposium on behalf of the 20th anniversary of the Red Cross Blood Bank “Zuid-West Nederland” (head: dr J.Ph.H.B. Sybesma) on November 27th 1997. A survey
|
Kuks, J.B.M |
|
1998 |
19 |
2 |
p. 129-136 8 p. |
artikel |
10 |
Stem Cells: What’s Happening? Focus on Quality Assurance, GMP and Regulatory Aspects
|
Seghatchian, M.J. |
|
1998 |
19 |
2 |
p. 191-192 2 p. |
artikel |
11 |
Surveillance for Factor VIII Inhibitor Development in the Canadian Hemophilia A Population Following the Widespread Introduction of Recombinant Factor VIII Replacement Therapy
|
Giles, A.R |
|
1998 |
19 |
2 |
p. 139-148 10 p. |
artikel |
12 |
The blood bank and hepatitis G
|
Araújo, Fernando |
|
1998 |
19 |
2 |
p. 119-120 2 p. |
artikel |
13 |
Therapeutic Cytokine Stimulation of Thrombocytopoiesis
|
Harker, Laurence A. |
|
1998 |
19 |
2 |
p. 149-162 14 p. |
artikel |